• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    OKYO Pharma Limited - Ordinary Shares (NQ: OKYO )

    1.090 UNCHANGED
    Streaming Delayed Price Updated: 3:48 PM EST, Nov 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,470
    Open 1.090
    Bid (Size) 1.100 (12)
    Ask (Size) 1.180 (5)
    Prev. Close 1.090
    Today's Range 1.090 - 1.090
    52wk Range 0.8075 - 2.120
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference
    From OKYO Pharma LTD
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga

    Performance

    YTD
    -43.81%
    -43.81%
    1 Month
    +9.48%
    +9.48%
    3 Month
    +11.57%
    +11.57%
    6 Month
    -26.35%
    -26.35%
    1 Year
    -35.50%
    -35.50%

    More News

    Read More
    3 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Announces Chairman Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Announces Chairman Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease
    From OKYO Pharma LTD
    Via GlobeNewswire
    Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    OKYO Pharma CEO Interview to Air on Bloomberg TV
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Announces Chairman Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma and SolarMax Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    OKYO Pharma Announces Chairman Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Granted European Patent Covering OK-101 Chemerin Analogs and Their Method of Use
    From OKYO Pharma LTD
    Via GlobeNewswire
    Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    OKYO Pharma to Initiate Neuropathic Corneal Pain Trial for OK-101
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Announces Promising Categorical Data from OK-101 Phase 2 Trial in Dry Eye Disease
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Announces Participation in May 2024 Investor Conferences
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma to Reschedule Key Opinion Leader Event in Dry Eye Disease to May 2024
    From OKYO Pharma LTD
    Via GlobeNewswire
    OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery
    From OKYO Pharma LTD
    Via GlobeNewswire
    Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Relief For Dry Eye Disease? OKYO Pharma's Candidate Shows Durable Pain Relief In Mid-Stage Study
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.